2EyesVision
  • SimVis Gekko
    • Product
    • Scientific Publications
    • FAQ’s
  • Testimonials
    • Clinicians Stories
  • Media
    • Press
    • ESCRS 2025
    • FacoElche 2026
  • Careers
    • Job Offers
  • About Us
    • Company Profile
    • Team
    • Advisory Board
    • Contact
  • How to Invest
  • Where to buy
Select Page
DMK and 2EyesVision announce partnership to bring SimVis Gekko to China

DMK and 2EyesVision announce partnership to bring SimVis Gekko to China

by 2EyesVision | Jun 15, 2026 | MáximoGómez, Press

Agreement strengthens the global expansion of SimVis Gekko and supports the adoption of real-world visual simulation in one of the world’s largest ophthalmology markets Guangzhou, China — 2EyesVision, the company behind SimVis Gekko, the world’s first...
FacoElche + CSIC + 2EyesVision Research Grant 2025: Award announcement

FacoElche + CSIC + 2EyesVision Research Grant 2025: Award announcement

by 2EyesVision | Jun 2, 2026 | Press

Ex aequo award to two centers: Vissum Miranza Alicante and Hospital San Rafael Madrid win the FacoElche+CSIC+2EyesVision Research Grant on halo measurement in intraocular lenses The exceptionally high quality of the applications received has led the evaluation...
FacoElche + CSIC + 2EyesVision Research Grant 2025: Award announcement

FacoElche + CSIC + 2EyesVision Research Grant 2025: anuncio del premio

by 2EyesVision | Jun 2, 2026 | Prensa

Premio ex aequo a dos centros: Vissum Miranza Alicante y el Hospital San Rafael Madrid ganan la Beca de Investigación FacoElche+CSIC+2EyesVision sobre la medición de halos en lentes intraoculares La calidad excepcionalmente alta de las solicitudes recibidas ha llevado...
Award-winning research redefining dominance using SimVis

Award-winning research redefining dominance using SimVis

by 2EyesVision | Apr 20, 2026 | Destacados, Press

Award-winning research redefining ocular dominance assessment using SimVis Gekko Washington DC, USA —  2EyesVision announces that the article “Assessing Ocular Dominance: Rethinking the Current Paradigm” has been honored with the Stephen A. Obstbaum Award for Best...
Award-winning research redefining dominance using SimVis

Investigación premiada que redefine la evaluación de la dominancia ocular con SimVis

by 2EyesVision | Apr 20, 2026 | Destacados, Prensa

Investigación premiada que redefine la evaluación de la dominancia ocular con SimVis Gekko Washington DC, EE. UU. — 2EyesVision anuncia que el artículo “Assessing Ocular Dominance: Rethinking the Current Paradigm” ha recibido el Premio Stephen A. Obstbaum al Mejor...
2EyesVision launches SimVis Academy for clinical adoption

2EyesVision launches SimVis Academy for clinical adoption

by 2EyesVision | Apr 14, 2026 | Press

The new e-learning platform enables clinicians to become certified in SimVis Gekko and integrate visual simulation into routine IOL counseling Madrid, Spain, April 2026 – 2EyesVision announces the launch of SimVis Academy, its new e-learning platform designed to...
2EyesVision launches SimVis Academy for clinical adoption

2EyesVision lanza SimVis Academy para impulsar su adopción clínica

by 2EyesVision | Apr 14, 2026 | Prensa

La nueva plataforma de e-learning permite a los profesionales clínicos certificarse en SimVis Gekko e integrar la simulación visual en el asesoramiento rutinario sobre LIO Madrid, España, abril de 2026 – 2EyesVision anuncia el lanzamiento de SimVis Academy, su nueva...
2EyesVision joins Fenin to strengthen its MedTech position

2EyesVision joins Fenin to strengthen its MedTech position

by 2EyesVision | Mar 25, 2026 | Destacados, Press

The company reinforces its role within Spain’s MedTech ecosystem as part of its growth and international expansion strategy Madrid, Spain — 2EyesVision, a company specialized in visual simulation technologies applied to ophthalmology, announces its incorporation into...
2EyesVision joins Fenin to strengthen its MedTech position

2EyesVision se une a Fenin para reforzar su posición en el sector MedTech

by 2EyesVision | Mar 25, 2026 | Destacados, Prensa

La compañía refuerza su papel dentro del ecosistema MedTech de España como parte de su estrategia de crecimiento y expansión internacional Madrid, España — 2EyesVision, compañía especializada en tecnologías de simulación visual aplicadas a la oftalmología, anuncia su...
2EyesVision engages Nivine Woods as Strategic Partner

2EyesVision engages Nivine Woods as Strategic Partner

by 2EyesVision | Mar 18, 2026 | Press, SusanaMarcos

2EyesVision has engaged Nivine Woods as Strategic Operating Partner and advisor to support the company’s expansion in the United States. In this capacity, Nivine will collaborate with the leadership team to guide U.S. market development and engagement with leading...
« Older Entries

Search

Recent Post

  • DMK and 2EyesVision announce partnership to bring SimVis Gekko to China
  • FacoElche + CSIC + 2EyesVision Research Grant 2025: anuncio del premio
  • FacoElche + CSIC + 2EyesVision Research Grant 2025: Award announcement
  • Investigación premiada que redefine la evaluación de la dominancia ocular con SimVis
  • Award-winning research redefining dominance using SimVis

Share it

At 2EyesVision, we create, develop and market innovative technologies in ophthalmology, endeavoring to make the life of eye care professionals and their patients easier.

Press

DMK and 2EyesVision announce partnership to bring SimVis Gekko to China

Jun 15, 2026

FacoElche + CSIC + 2EyesVision Research Grant 2025: Award announcement

Jun 2, 2026

Award-winning research redefining dominance using SimVis

Apr 20, 2026

Quick Access

  • SimVis Gekko
  • Scientific Publications
  • Careers
  • Team
  • Where to buy
  • How to Invest

Legal

  • Cookies Policy
  • Privacy Policy
  • Quality Manual Policy
  • Gender Equality Plan

Contact



Email

hello@2eyesvision.com



Headquarters

Pl. de la Encina, 10
Tres Cantos (28760)
Madrid, Spain

  • Follow
  • Follow
  • Follow
  • Follow
2EyesVision Copyright © 2026 | All Rights Reserved.

Design by Papaya Digital

Manage cookie consent
To provide the best experiences, we use technologies such as cookies to store and/or access information on your device. Consenting to these technologies will allow us to process data such as browsing behaviour or unique identifiers on this site. Not consenting, or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferencias
El almacenamiento o acceso técnico es necesario para la finalidad legítima de almacenar preferencias no solicitadas por el abonado o usuario.
Statistics
El almacenamiento o acceso técnico que es utilizado exclusivamente con fines estadísticos. Technical storage or access that is used exclusively for anonymous statistical purposes. Without a request, voluntary compliance by your Internet Service Provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Technical storage or access is necessary to create user profiles to send advertising, or to track the user across a website or across multiple websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}